Research Findings Researchers have observed that MOTS-c may: Improve cellular resilience Support metabolic health Enhance adaptation to physiological stress Promote healthy aging processes Anxiety and Stress Implications Although direct anxiety research remains limited, better metabolic and mitochondrial function may contribute to improved stress resilience and overall well-being
Safety data were analysed descriptively by treatment group (oral semaglutide 3 mg, 7 mg, 14 mg, flexibly dosed, and comparators) and background medication/insulin regimen subgroup for all patients in the trials for the incidence of adverse events (AEs), including serious AEs, gastrointestinal AEs and genitourinary AEs, as well as events leading to trial product discontinuation and hypoglycaemic episodes
Many patients achieve optimal results through medication alone, without additional interventions that could trigger side effects
(Skip ahead to read about the safety limits of stretching your pen supply.) Minimizing Side Effects and Improving Tolerance Gastrointestinal disturbances are the most common side effects of GLP-1 medications, affecting approximately 50% to 60% of patients during the initial treatment phase